DUBLIN–(BUSINESS WIRE)–The “Exosome Diagnostics, Therapeutics and Research Tools: Global Markets” report has been added to ResearchAndMarkets.com’s offering.
The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.
The global market for exosome diagnostics and therapeutics saw revenue data amounting to a significant figure in 2021-2022, with estimates for 2023 and forecasts for 2024 projecting robust growth. The market is expected to witness a strong compound annual growth rate (CAGR) through 2028. This analysis provides a comprehensive estimate of the current market size and revenue growth prospects, alongside a detailed market share analysis based on product, application, end user, and region.
Market Drivers, Opportunities, and Restraints
Key market drivers include the growing application of exosome diagnostics in personalized medicine and the rising prevalence of chronic diseases. Opportunities abound in the expanding research activities related to exosomes and their therapeutic potential. However, market growth is restrained by factors such as high costs associated with exosome isolation and the complexity of regulatory pathways. Macroeconomic variables also play a crucial role in shaping the market dynamics.
Emerging Technologies, Regulations, and R&D Efforts
The market is experiencing significant advancements in emerging technologies related to exosome diagnostics and therapeutics. There is a strong emphasis on regulatory frameworks and R&D efforts aimed at enhancing the efficacy and safety of exosome-based products. These developments are crucial in facilitating new commercial opportunities in diagnostics, therapeutics, and research tools markets.
Commercial Opportunities and Trends
New commercial opportunities are emerging in the diagnostics, therapeutics, and research tools markets. Trends such as the development of novel assay technologies and innovative products are driving market growth. The use of exosome proteins and nucleic acids as diagnostic biomarkers is gaining traction, particularly in microRNA, liquid biopsy, and stem cell research industries.
Patent Analysis and Sustainability Trends
Relevant patents in the U.S., Europe, and Japan are analyzed to provide insights into the technological advancements and intellectual property landscape in exosome diagnostics and therapeutics. Additionally, sustainability trends and ESG developments are reviewed, highlighting consumer attitudes, companies’ ESG score rankings, and their sustainability practices.
Competitive Landscape
The competitive landscape is thoroughly analyzed, including companies’ market shares, business segments, financials, and product portfolios. Recent mergers and acquisitions (M&A) activity and a venture funding outlook are also discussed, providing a clear picture of the industry’s competitive dynamics. Company profiles of major players such as Bio-Techne, Exosomics S.p.A., and System Biosciences LLC are included to offer detailed insights into their strategies and market positioning.
Company Profiles
Acousort Ab
Aegle Therapeutics
Aethlon Medical Inc.
Aruna Bio Inc.
Bio-Techne
Capricor Therapeutics Inc.
Caris Life Sciences
Direct Biologics Llc
Exosomics Spa
Evox Therapeutics Ltd.
Kimera Labs
Lonza
Mir Scientific
Nano Med
Nanosomix
Rion
System Biosciences Llc
Key Topics Covered:
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Exosome Basics
Exosome Biogenesis and Processing
Exosome Function and Physiology
Intracellular Communication
Facilitation of the Immune Response
Tissue Regeneration
Bioinformatic Databases for Exosome Research and Product Development
ExoCarta
Vesiclepedia
EVpedia
Chapter 3 Market Dynamics
Overview
Market Drivers
Increasing Investment in Biomedical Research
Trend Towards Precision Medicine
Technological Advancements in Exosome Research Tools
Restraints
Evolving Regulatory Landscape
Lack of Well-Characterized Exosome Standards
Opportunities
Growing Popularity in Liquid Biopsy
Benefits Over Stem Cell Therapy
Challenges
Funding Issues
Chapter 4 Regulatory Landscape
U.S.
Exosome Therapeutics
Exosome Clinical Assays Development and Marketing
Chapter 5 Emerging Technologies and Developments
Emerging Technologies
Engineered Exosomes
Microfluidic Technology
Exosome Research Services
Exosome Based Liquid Biopsy Tests
Clinical Trial Analysis
Overview
By Phases
By Funder Type
By Disease Type
By Country
Pipeline Analysis
Chapter 6 Market Segmentation Analysis
Segmental Breakdown
Market Analysis by Application Type
Diagnostics and Monitoring
Evaluation of the Diagnostics and Monitoring Market
Cancer
CNS Disorders and Neurodegeneration Diseases
Organ Transplantation
Cardiovascular Diseases
Others
Diagnostics and Monitoring Market Revenue
Exosome Therapeutics
Potential Therapeutic Applications
Evaluation of the Current and Potential Therapeutics Market
Key Target Indications
Research Tools and Regents
Research Tools and Reagents Market Revenue
Geographic Breakdown
North America
Europe
Asia-Pacific
Rest of the World (RoW)
Chapter 7 Competitive Intelligence
Overview
Exosome-Based Clinical Diagnostics Market
Market Participants in the Exosome-Based Clinical Diagnostics Market
Exosome-Based Therapeutics Market
Market Participants in the Exosome-Based Therapeutics Market
Exosome Research Tools and Reagents Market
Market Participants in the Exosome Research Tools and Reagents Market
Key Strategies
Opportunities and Challenges in the Exosome Market
Chapter 8 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/goynks
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
